US Bill Seeks To Eliminate Biosimilar Interchangeability Trial Burden

‘Biosimilar Red Tape Elimination Act’ Would Remove Need For Switching Studies

 
• By Dave Wallace
  
Scissors cutting red tape
The bill is aimed at eliminating “red tape and unnecessary studies” • Source: Shutterstock

More from Policy & Regulation

More from Generics Bulletin